Non-alcoholic steatohepatitis, or NASH, is the most severe form of non-alcoholic fatty liver disease (NAFLD). NASH is more than a liver disease, it is a complex cardio-metabolic disease with no approved treatment and represents a growing concern for the medical community. It is estimated that 12% of the adult population in the US has NASH and most are undiagnosed. This spectrum of non-alcoholic fatty liver disease is growing to become the most common chronic liver condition in Western populations, in relation to the obesity and type 2 diabetes epidemics, and the prevalence of NASH is also expected to increase.

In this conference, well-known experts in NASH will provide information on the disease progression and outcomes and discuss the challenges that the medical community faces. The speakers will also present current scientific, medical and advocacy projects aiming to address the public health crisis that represents NASH.  

The conference is open to healthcare professionals, representants of public health authorities, patient groups, professional and academic organizations, patients and their family, industry.

Program and speakers

Full program

2:30 - 3:00 PM – Welcoming of attendees

3:00 - 3:10 PM – Introductory speech

3:10 - 3:40 PM – NASH, a looming public health crisis

• NASH: what is it and what are the outcomes?
• Epidemiology and socio-economic burden of NASH

3:40 - 4:10 PM – Challenges in the current practices for the diagnosis and management of high risk population

• Lack of awareness in the patient and healthcare communities
• Lack of treatment options
• Lack of guidance/recommendation for high risk population & current bottleneck with diagnosis

4:10 - 4:20 PM – Coffee break

4:20 - 4:50 PM – What is on the horizon for NASH diagnostic

• New diagnostics programs
• Creating a standard of care

4:50 - 5:20 PM – Panel Discussion – Unmet needs and building consensus

• “Beyond the biopsy” campaign – Global Liver Institute
• Panel discussion with physicians and patients

5:20 – 5:30 PM Conclusion

5:30 - 6:30 PM – Reception and closing

Confirmed participation of:

• Moderator: Dr. Nicole Harris-Hollingsworth, Montefiore Health System - Albert Einstein College of Medicine
• Dr Julia Wattacheril, Columbia University Irving Medical Center
• Dr. Amreen Dinani, Mount Sinai
• Dr. Amon Asgharpour, Mount Sinai
• Richard Gelula, Global Liver Institute

Join us or watch online

You cannot travel to New York City? The conference will be live broadcast on The NASH Education Program's website. Register online by selecting Live Webcast Ticket - I will watch online to receive the link of the Live Webcast on June 12.